By Mike Dolan Dec 16 - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets The ...
52mon MSN
Where will Eli Lilly be in 10 years?
Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). The company overtook early GLP-1 leader Novo Nordisk. Eli Lilly is increasingly reliant on its GLP-1 drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback